Company profile: NuVision Biotherapies
1.1 - Company Overview
Company description
- Provider of high-quality, affordable biotherapies for treating front-of-the-eye disease and trauma. A biotechnology research and development spin-out from the University of Nottingham, incorporated in July 2014 to commercialise ophthalmic biotherapies.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NuVision Biotherapies
Cerapedics
HQ: United States
Website
- Description: Provider of novel osteobiologic medical devices, including the i-FACTOR Peptide Enhanced Bone Graft, a biologic graft of synthetic peptide (P-15) bound to an anorganic bone mineral to support bone growth by enhancing natural healing. Also conducts the ASPIRE IDE pivotal study evaluating a next-generation product for lumbar interbody fusion, which has FDA Breakthrough Device Designation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cerapedics company profile →
Lotus Tissue Repair
HQ: United States
Website
- Description: Provider of proprietary recombinant human collagen Type VII (rC7) technology for accelerating chronic wound healing in dermatologic conditions, including diabetic foot ulcers, venous stasis ulcers and similar conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lotus Tissue Repair company profile →
PolarityTE
HQ: United States
Website
- Description: Provider of SkinTE, an investigational product for complex chronic and acute wound treatment that uses a patient's own tissue to regenerate functional skin, and a clinical development program advancing SkinTE through clinical trials to obtain regulatory approval.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PolarityTE company profile →
RestoreFlow
HQ: United States
Website
- Description: Provider of research into restorative transplantation of donated human tissue for medical treatment, operating in the healthcare industry; incorporated in 2013 and based in Chicago, Illinois.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RestoreFlow company profile →
Regentys
HQ: United States
Website
- Description: Provider of early-stage regenerative medicine and innovative medical devices for gastrointestinal applications, including ECMH (Extracellular Matrix Hydrogel), a porcine-derived extracellular matrix hydrogel designed to create an environment favorable for new tissue growth to replace diseased or damaged tissue in the gastrointestinal tract.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Regentys company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NuVision Biotherapies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NuVision Biotherapies
2.2 - Growth funds investing in similar companies to NuVision Biotherapies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NuVision Biotherapies
4.2 - Public trading comparable groups for NuVision Biotherapies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →